RMD
Resmed
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: RMD
- PEG Ratio
Resmed currently trades with a PEG ratio of 1.17, based on Jul 13, 2026 data. Dividing the 19.09 PE ratio by the 16.3% earnings growth rate produces this figure. Relative to the 1.05 average from the past 4 quarters, the PEG ratio rose by 12%.
RMD PEG ratio history
Historically, Resmed maintains a PEG ratio averaging 5.28 across the last nine years. At 1.17, today's PEG ratio sits 78% lower than its historical average. The nine years high came in the Dec 2019 quarter at 81.48, reflecting peak valuation relative to growth. The bottom was reached in the Sep 2020 quarter at 0.6, suggesting favorable value relative to growth during that period.
Resmed PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.72 | 27.02 | 37.6% |
| 2024 | 2.06 | 27.58 | 13.4% |
| 2023 | 2.45 | 35.7 | 14.6% |
| 2022 | 0.62 | 39.26 | 63.3% |
| 2021 | N/A | 75.39 | -24.1% |
| 2020 | 0.85 | 44.55 | 52.3% |
| 2019 | 1.53 | 43.12 | 28.1% |
| 2018 | N/A | 46.87 | -8.7% |
| 2017 | N/A | 32.18 | -3.6% |
| 2016 | N/A | 25.19 | 0% |
| 2015 | 7.74 | 22.46 | 2.9% |
| 2014 | 1.54 | 20.75 | 13.5% |
| 2013 | 0.92 | 20.99 | 22.9% |
| 2012 | 1.02 | 17.83 | 17.4% |
| 2011 | 1.13 | 20.77 | 18.3% |
Resmed PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 1.32 | 21.58 | 16.3% |
| Dec 2025 | 1.21 | 23.73 | 19.6% |
| Sep 2025 | 0.94 | 27.9 | 29.8% |
| Jun 2025 | 0.72 | 27.02 | 37.6% |
| Mar 2025 | 0.67 | 25.04 | 37.1% |
| Dec 2024 | 0.67 | 26.94 | 40.1% |
| Sep 2024 | 1.44 | 32.29 | 22.5% |
| Jun 2024 | 2.06 | 27.58 | 13.4% |
| Mar 2024 | 2.84 | 30.37 | 10.7% |
| Dec 2023 | 2.96 | 28.39 | 9.6% |
| Sep 2023 | 1.63 | 23.97 | 14.7% |
| Jun 2023 | 2.45 | 35.7 | 14.6% |
| Mar 2023 | 3.68 | 37.18 | 10.1% |
| Dec 2022 | 0.7 | 37.64 | 54% |
| Sep 2022 | 0.73 | 40.58 | 55.9% |
RMD average PEG ratio chart
RMD's PEG ratio today comes in under the 3, 5 and 10-year averages.
PEG comparison
With a PEG of 1.17, RMD ranks higher than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.57, Resmed's PEG is 105% higher.
RMD EPS growth
RMD Price vs fair value
RMD PEG vs peers
Among its peers, RMD has a PEG ratio below stocks TMO and MDT, while higher than ELMD's.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| ELMD Electromed Inc | 0.8 | $380.8M |
| RMD Resmed Inc | 1.17 | $28.79B |
| TMO Thermo Fisher Scientific Inc | 4.4 | $196.41B |
| MDT Medtronic plc | 6.75 | $106.97B |
| INGN Inogen Inc | N/A | $177.07M |
Frequently asked questions
What is Resmed's PEG ratio?
Based on Jul 13, 2026 data, RMD shows a PEG ratio of 1.17.
What is the 3-year average PEG ratio for Resmed (RMD)?
RMD shows a 3-year average PEG ratio of 1.5.
What is the 5-year average PEG ratio for Resmed (RMD)?
RMD shows a 5-year average PEG ratio of 1.49.
What is the highest PEG ratio for RMD?
The Dec 2019 quarter marked the nine years high at 81.48 for RMD's PEG ratio.
How does the current PEG ratio for RMD compare to its historical average?
Compared to the 9-year average, RMD's PEG ratio sits 78% lower.
How is RMD's PEG ratio calculated (Resmed PEG ratio formula)?
Computing the PEG ratio involves dividing the PE ratio by the company's EPS growth rate (YoY TTM). As of Jul 13, 2026, Resmed carries a PE ratio of 19.09. Earnings grew at 16.3% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 1.17. PEG RATIO(1.17) = PE RATIO(19.09) / EPS GROWTH(16.3%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.